Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001499736 | SCV001704507 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV003584906 | SCV004356699 | likely benign | Hereditary cancer-predisposing syndrome | 2019-03-19 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001354312 | SCV001548898 | likely benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | The MSH2 c.1760-12A>G variant was not identified in the literature nor was it identified in the ClinVar or UMD-LSDB. The variant was identified in dbSNP (ID: rs774350590) as "NA". The variant was identified in control databases in 2 of 276256 chromosomes at a frequency of 0.000007 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 1 of 23988 chromosomes (freq: 0.000042), East Asian in 1 of 18834 chromosomes (freq: 0.000053), but not in the Other, Latino, European Non-Finnish, Ashkenazi Jewish, Finnish, and South Asian populations. The c.1760-12A>G variant is not highly conserved and is located in the 3' splice region but does not affect the invariant -1 and -2 positions. However, positions -3 and -5 to -12 are part of the splicing consensus sequence and variants involving these positions sometimes affect splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. |